Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
80.00
-0.80 (-0.99%)
At close: Sep 17, 2025, 4:00 PM EDT
80.70
+0.70 (0.88%)
After-hours: Sep 17, 2025, 7:24 PM EDT
Inspire Medical Systems Market Cap
Inspire Medical Systems has a market cap or net worth of $2.37 billion as of September 17, 2025. Its market cap has decreased by -56.75% in one year.
Market Cap
2.37B
Enterprise Value
2.10B
1-Year Change
-56.75%
Ranking
Category
Stock Price
$80.00
Market Cap Chart
Since May 3, 2018, Inspire Medical Systems's market cap has increased from $505.61M to $2.37B, an increase of 367.94%. That is a compound annual growth rate of 23.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.39B | -56.98% |
| Dec 31, 2024 | 5.56B | -7.51% |
| Dec 29, 2023 | 6.01B | -17.47% |
| Dec 30, 2022 | 7.28B | 15.62% |
| Dec 31, 2021 | 6.29B | 24.23% |
| Dec 31, 2020 | 5.07B | 191.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |